Literature DB >> 24612735

Tumor endoprosthesis revision rates increase with peri-operative chemotherapy but are reduced with the use of cemented implant fixation.

Luke R Pugh1, Paul W Clarkson1, Amy E Phillips1, David J Biau2, Bassam A Masri1.   

Abstract

Chemotherapy may reduce osseointegration of tumor endoprosthesis, while delaying chemotherapy may reduce survival. We studied the effects of chemotherapy and cemented fixation on tumor endoprosthesis survivorship with a retrospective analysis of 50 consecutive patients receiving lower limb salvage surgery. We compared rates of radiographic loosening/revision and effect of cement fixation between chemotherapy/no chemotherapy cohorts. Chemotherapy increased the total revision rate (HR = 3.8 [1-14], P = 0.033), but did not affect aseptic loosening. Cement fixation reduced revision for loosening (HR = 0.09 (0.008-0.98), P = 0.012) and showed less radiographic loosening (HR = 0.09 (0.02-0.51), P = 0.00066). Cement fixation had lower rates of revision for loosening and radiographic loosening regardless of whether chemotherapy was given. We conclude that for these implants, cement fixation provides superior results to uncemented fixation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cementation; chemotherapy; endoprosthesis; implant survivorship; malignancy; surgical fixation

Mesh:

Substances:

Year:  2014        PMID: 24612735     DOI: 10.1016/j.arth.2014.01.010

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  CORR Insights®: Chemotherapy Curtails Bone Formation From Compliant Compression Fixation of Distal Femoral Endoprostheses.

Authors:  Christopher P Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

2.  Radiographic assessment of distal femur cemented stems in tumor endoprostheses.

Authors:  R E Turcotte; N A Stavropoulos; J Toreson; M Alsultan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-28

3.  CORR Insights®: Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Nononcologic Conditions After Distal Femur Replacement?

Authors:  Carlos A Higuera-Rueda
Journal:  Clin Orthop Relat Res       Date:  2020-05       Impact factor: 4.755

4.  Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Non-oncologic Conditions After Distal Femur Replacement?

Authors:  Kevin Staats; Klemens Vertesich; Irene K Sigmund; Branden Sosa; Alexandra Kaider; Phillip T Funovics; Reinhard Windhager
Journal:  Clin Orthop Relat Res       Date:  2020-05       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.